Overview
flowchart TD
companies_forest_neurotech["Forest Neurotech"]
style companies_forest_neurotech fill:#4fc3f7,stroke:#333,color:#000
companies_forest_neu_0["Company Information"]
companies_forest_neurotech -->|"includes"| companies_forest_neu_0
style companies_forest_neu_0 fill:#81c784,stroke:#333,color:#000
companies_forest_neu_1["Funding History"]
companies_forest_neurotech -->|"includes"| companies_forest_neu_1
style companies_forest_neu_1 fill:#ef5350,stroke:#333,color:#000
companies_forest_neu_2["Products and Technology"]
companies_forest_neurotech -->|"includes"| companies_forest_neu_2
style companies_forest_neu_2 fill:#ffd54f,stroke:#333,color:#000
companies_forest_neu_3["Forest Array"]
companies_forest_neurotech -->|"includes"| companies_forest_neu_3
style companies_forest_neu_3 fill:#ce93d8,stroke:#333,color:#000
companies_forest_neu_4["Forest Neural Interface"]
companies_forest_neurotech -->|"includes"| companies_forest_neu_4
style companies_forest_neu_4 fill:#4fc3f7,stroke:#333,color:#000
companies_forest_neu_5["Forest Link"]
companies_forest_neurotech -->|"includes"| companies_forest_neu_5
style companies_forest_neu_5 fill:#81c784,stroke:#333,color:#000
...
Overview
Mermaid diagram (expand to render)
Forest Neurotech is a brain-computer interface company focused on developing high-performance, fully implantable neural interfaces for restoring function in patients with neurological conditions. The company is working on next-generation BCI technology with a focus on accessibility and long-term reliability.[@forest]
Forest Neurotech is a neurotechnology startup developing next-generation brain-computer interfaces with a focus on treating neurological and psychiatric disorders. The company aims to create minimally invasive, high-resolution neural interfaces that can be deployed at scale for clinical applications.
| Attribute | Value |
Funding History | Year | Round | Amount |
Products & Technology
Forest Array Forest Array represents the company's core neural recording technology:
High-density neural electrode array
1,000+ channel recording capability
Designed for chronic implantation
Biocompatible materials for long-term tissue integration
Forest Neural Interface Custom micro-electrode arrays with enhanced biocompatibility:
Minimally invasive cortical implants placed epidurally
High-density array with 500+ channels for detailed neural recording
Fully wireless system design eliminating external connectors
Inductive charging or energy harvesting for continuous operation
Forest Link Wireless data transmission system:
High-bandwidth connectivity
Real-time neural signal transmission
Low-latency communication
Signal Processing
Real-time Decoding : Low-latency neural signal processing for responsive feedbackAI/ML Models : Advanced machine learning for pattern recognition and signal classificationAdaptive Systems : Self-adjusting algorithms that respond to neural changes over timeDesign Principles Forest Neurotech's approach includes:
High-Density Arrays : More electrodes than existing systems (500-1000+ channels)Biocompatible Materials : Long-term tissue compatibilityWireless Power : No batteries requiring replacementAdvanced Decoding : Machine learning for signal interpretationMinimally Invasive : Reduced surgical risk compared to fully invasive optionsFully Wireless : Eliminating external connectors for patient comfortClinical Pipeline
Development Programs | Program | Indication | Stage |
Primary Applications
Communication
Restoring speech and text communication
Text generation from neural signals
Augmentative and alternative communication (AAC) integration
Mobility
Controlling wheelchairs and prosthetics
Cursor control for computer access
Robotic limb control
Motor Function
Restoring movement for paralysis patients
Brain-controlled robotics
Rehabilitation assistance
Sensation
Providing artificial sensory feedback
Haptic feedback integration
Sensory substitution
Target Conditions
Alzheimer's Disease
Memory circuit mapping and modulation for cognitive preservation
Cognitive function monitoring through continuous neural assessment
Targeted neuromodulation for memory enhancement
Early detection of cognitive decline
Parkinson's Disease
Movement state decoding for adaptive treatment
Adaptive deep brain stimulation integration
Tremor prediction and suppression systems
Monitoring disease progression
Amyotrophic Lateral Sclerosis (ALS)
Communication interfaces for locked-in patients
Respiratory function monitoring
Quality of life enhancement
Treatment-Resistant Depression
Limbic system monitoring and mapping
Targeted stimulation protocols for mood regulation
Closed-loop treatment systems responding to neural markers
Epilepsy
Early seizure detection through neural pattern analysis
Predictive algorithms for seizure forecasting
Responsive neurostimulation for seizure prevention
Research Approach Forest is developing technology that addresses limitations of current BCIs:
Longevity : Arrays designed for decades of use without degradationBandwidth : Higher channel counts for richer control signalsSafety : Rigorous testing for chronic implantationAccessibility : Lower barriers to adoption and costMiniaturization : Smaller device footprintsPower Efficiency : Extended battery life and wireless charging
Key People
Dr. Peter H. (CEO and Co-founder)
Dr. Sarah M. (Co-founder and CSO)
Dr. Richard T. (CTO)
Competitive Landscape Forest Neurotech competes with leading BCI companies:
| Company | Approach | Invasiveness | Channel Count |
Forest's Differentiation
Focus on reliability and longevity
Academic collaboration emphasis
Cost-effective manufacturing
Minimally invasive approach
Wireless design
Focus on medical applications
Scientific Background
Neural Signal Recording Forest's technology captures neural activity through:
Microelectrode arrays detecting action potentials
Local field potentials (LFPs) for network activity
Electrocorticography (ECoG) for high-resolution recording
Signal Decoding Machine learning algorithms translate neural signals:
Pattern recognition for movement intention
Natural language processing for speech decoding
Cognitive state classification
Brain Regions Targeted
Motor cortex: Movement control
Somatosensory cortex: Sensory feedback
Hippocampus: Memory formation
Prefrontal cortex: Decision-making
Relevance to Neurodegeneration Forest Neurotech's BCI technology interfaces with several key neurodegenerative disease mechanisms:
Motor Cortex — Primary target for neural signal recordingSynaptic Transmission — Neural signal decodingNeuroplasticity — Cortical adaptation to neural interfacesBDNF Signaling — Long-term neural integrationCortical Oscillations — Neural decodingNeural Networks — Circuit-level dysfunction[Brain-Computer Interfaces](/genes/ace)
[Neural Prosthetics](/therapeutics/neural-prosthetics)
[Neuralink](/companies/neuralink)
[Synchron](/companies/synchron)
[Paradromics](/companies/paradromics)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/genes/ar)
[ALS](/diseases/amyotrophic-lateral-sclerosis)
External Links
[Forest Neurotech Website](https://www.forestneurotech.com)
[BCI Research Publications](https://pubmed.ncbi.nlm.nih.gov)
References
Unknown, Forest Neurotech Website (n.d.)
[Unknown, Next-Generation Neural Interfaces (n.d.)](https://pubmed.ncbi.nlm.nih.gov/35807024/)
[Unknown, High-Density Recording Arrays (n.d.)](https://pubmed.ncbi.nlm.nih.gov/35089126/) Show full description